openPR Logo
Press release

Cytomegalovirus Infection Treatment and Diagnosis Market Key Players Merck & Co. Inc., Cell Medical Ltd., Chimerix, Inc., Affymetrix, Inc., Abbott Laboratories, Inc., Becton

03-16-2019 05:34 AM CET | Energy & Environment

Press release from: Coherent Market Insights

Cytomegalovirus Infection

Cytomegalovirus Infection

Cytomegalovirus (CMV) is a virus that belongs to herpes virus family that remain dormant in the human body. CMV infection can occur in people of all ages worldwide. CMV is a communicable disease that spreads through body fluids such as saliva, blood, urine, semen, and breast milk. Presence of CMV infection can be detected by various testing methods based on which the global cytomegalovirus infection treatment and diagnosis market can be analyzed: Serologic test, Polymerase chain reaction (PCR) test,.
CMV diagnosis is very critical in pregnant women and immunocompromised individuals. Enzyme-linked immunoassay test is the most widely used serologic testing for CMV infection in laboratories. Besides, PCR technique is also widely implemented for samples of saliva, and urine. Awareness about the infection is essential as most of the cases go undiagnosed at early stages as the disease is asymptomatic.

Get Exclusive Sample Copy @ www.coherentmarketinsights.com/insight/request-sample/167

People diagnosed with high risk of CMV infection may be given anti-viral medications to prevent the disease to get in to active stage. There is no cure available for treating the CMV infection. Ganciclovir, Val ganciclovir, Cidofovir, Valacyclovir and Foscarnet are few major anti-viral medications prescribed. In some cases, CMV immune globulin contains antibodies (proteins) may be prescribed to prevent CMV infection. There are certain products in pipeline which includes Cytovir CMV, Letermovir, CytoTect CP 70, Brincidofovir and ASP0113, commercialization of which is expected to fuel the global CMV infection treatment and diagnosis market growth in the near future.

Besides, diagnosis of new CMV cases would be a propelling factor for global cytomegalovirus infection treatment and diagnosis market. The Public Health Agency of Canada estimates that 40%-100% of the global population have CMV antibody present in their body. Immunocompromised patients (HIV, organ transplant), premature infants, newborns and with congenital CMV are at high risk of developing serious illness with CMV infection.

According to the Centers for Disease Control and Prevention (CDC), one in every 150 infants are born with congenital cytomegalovirus (CMV) infection in the U.S. However, only one in five infants infected with CMV have long term health problems. Prevailing infection rates and demand for effective treatment therapies would be thrusting the cytomegalovirus infection treatment and diagnosis market growth.

Read Full Report with TOC @ www.coherentmarketinsights.com/ongoing-insight/toc/167

Some of the major players in the global cytomegalovirus infection treatment and diagnosis market are Merck & Co. Inc., Cell Medical Ltd., Chimerix, Inc., Affymetrix, Inc., Abbott Laboratories, Inc., Becton, Dickinson and Company, Johnson & Johnson, Bio-Rad Laboratories, Inc., and F. Hoffmann-La Roche Ltd.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cytomegalovirus Infection Treatment and Diagnosis Market Key Players Merck & Co. Inc., Cell Medical Ltd., Chimerix, Inc., Affymetrix, Inc., Abbott Laboratories, Inc., Becton here

News-ID: 1657720 • Views: 404

More Releases from Coherent Market Insights

Smart Camera Market Accrues Phenomenally by 2026 with a Staggering CAGR
The Report on Smart Camera Market 2018-2026 sheds light on the important developments impacting and increasing the growth of the Smart Camera Market including its restraints, drivers and prospects. The Smart Camera Market report proposes complete synopsis of the market, covering several characteristics such as product definition, market breakdown based on several constraints, supply chain analysis, and the fundamental Key Players outlook. You Keep Your Social Distance And We Provide You
New Developments with Operational Updates in Automotive Pumps Market
The Report on Automotive Pumps Market 2018-2026 sheds light on the important developments impacting and increasing the growth of the Automotive Pumps Market including its restraints, drivers and prospects. The Automotive Pumps Market report proposes complete synopsis of the market, covering several characteristics such as product definition, market breakdown based on several constraints, supply chain analysis, and the fundamental Key Players outlook. You Keep Your Social Distance And We Provide You
Smart Factory Market Development Status To 2026 Estimated By Global Key Players
The Report on Smart Factory Market 2018-2026 sheds light on the important developments impacting and increasing the growth of the Smart Factory Market including its restraints, drivers and prospects. The Smart Factory Market report proposes complete synopsis of the market, covering several characteristics such as product definition, market breakdown based on several constraints, supply chain analysis, and the fundamental Key Players outlook. You Keep Your Social Distance And We Provide You
Peer-to-Peer Lending Market - Comprehensive Evaluation Of The Market Via In-Dept …
The Report on Peer-to-Peer Lending Market 2018-2026 sheds light on the important developments impacting and increasing the growth of the Peer-to-Peer Lending Market including its restraints, drivers and prospects. The Peer-to-Peer Lending Market report proposes complete synopsis of the market, covering several characteristics such as product definition, market breakdown based on several constraints, supply chain analysis, and the fundamental Key Players outlook. You Keep Your Social Distance And We Provide You

All 5 Releases


More Releases for CMV

Cytomegalovirus (CMV) Test Market to Develop Rapidly by 2026
Cytomegalovirus (CMV) is a common virus that occurs widely among the population. In the U.S., 50%-85% of adults have been infected with cytomegalovirus (CMV). Most people who are infected with the virus do not experience any significant symptoms or health problems. CMV testing involves either a measurement of cytomegalovirus antibodies, immune proteins produced in response to CMV exposure, or the detection of the virus itself. CMV is found in many
Cytomegalovirus (CMV) Market: Size, Status, Opportunity Analysis and Forecasts t …
A new independent 162 page research with title 'Cytomegalovirus (CMV): Opportunity Analysis and Forecasts to 2027' guarantees you will remain better informed than your competition. The study covers geographic analysis that includes regions like North America, Europe or Asia and important players/vendors such as Atara Bio, Biotest AG, Helocyte, Merck & Co., Novartis, Shire, ViraCyte With n-number of tables and figures examining the Cytomegalovirus (CMV) Market, the research gives
Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market Opportunity Analy …
Cytomegalovirus (CMV) is a virus that belongs to herpes virus family that remain dormant in the human body. CMV infection can occur in people of all ages worldwide. CMV is a communicable disease that spreads through body fluids such as saliva, blood, urine, semen, and breast milk. Presence of CMV infection can be detected by various testing methods based on which the global cytomegalovirus infection treatment and diagnosis market can
Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market: Rise i …
Some of the prominent names in the global human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market are Valeant Pharmaceuticals, Roche AG, Perrigo Company plc, Fougera Pharmaceuticals, Clinigen Group plc., and Fresenius Kabi USA. Of them, Valeant Pharmaceuticals accounts for a leading share in the HPV therapeutics market and Roche AG accounts for a dominant share in the CMV therapeutics market. Read Report Overview @ https://www.transparencymarketresearch.com/hpv-cmv-therapeutics-market.html A report by Transparency Market Research forecasts
Cytomegalovirus (CMV) Diagnostics Market Forecast Research Reports Offers Key In …
Cytomegalovirus belongs to the herpesviridae family and is a double-stranded DNA virus. This virus mainly causes asymptomatic infections or sometimes causes mild flu like symptoms; and later remains latent throughout life, which may reactivate. Thus, this virus can remain as a lifelong companion for some individuals and can be a silent killer for the others. Cytomegalovirus (CMV) infection is characterized by the development of such antibodies, which develop due to
Cytomegalovirus (CMV) Infection Therapeutics Pipeline Analysis, 2017 by P&S Mark …
The rising number of the research and development activities for the pipeline drugs acts as drivers for the cytomegalovirus infection therapeutics pipeline. The prophylaxis treatment of cytomegalovirus is also increasing due to its effective and safe treatment. The U.S. Food and Drug Administration (USFDA) and European Medicines Agency (EMA) are supporting the cytomegalovirus infection therapeutics pipeline by encouraging the drug development process through different types of designations. The pipeline is